Trial · NCT00262080
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Treatment Outcome Score at 4 Hours Post-Dose | Ecallantide | 49.5 | Standard Deviation 59.43 | units on a scale | |
| Treatment Outcome Score at 4 Hours Post-Dose | Placebo | 18.5 | Standard Deviation 67.78 | units on a scale | |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Ecallantide | MSCS Score at baseline | 2.17 | Standard Deviation 0.51 | units on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Placebo | MSCS Score at baseline | 2.24 | Standard Deviation 0.55 | units on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Ecallantide | MSCS Score at 4 hours post-dose | 1.26 | Standard Deviation 0.96 | units on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Placebo | MSCS Score at 4 hours post-dose | 1.75 | Standard Deviation 0.90 | units on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Ecallantide | Change from baseline in MSCS at 4 hours post-dose | -0.91 | Standard Deviation 1.10 | units on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hours Post-dose | Placebo | Change from baseline in MSCS at 4 hours post-dose | -0.48 | Standard Deviation 0.68 | units on a scale |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Ecallantide | Internal Head/Neck Symptoms | 9 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Placebo | Internal Head/Neck Symptoms | 4 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Ecallantide | Stomach/GI | 19 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Placebo | Stomach/GI | 22 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Ecallantide | Genital/Buttocks | 2 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Placebo | Genital/Buttocks | 4 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Ecallantide | External Head/Neck | 5 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Placebo | External Head/Neck | 8 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Ecallantide | Cutaneous | 21 | participants | |
| Number of Patients With Symptom Complexes of Treated Attack at Baseline(DOUBLE-BLIND PART) | Placebo | Cutaneous | 14 | participants | |
| Treatment Outcome Score at 4 Hours Post-Dose Over Multiple Treatment Episodes | Ecallantide | Episode 1 (n =18) | 71.3 | Standard Deviation 28.85 | units on a scale |
| Treatment Outcome Score at 4 Hours Post-Dose Over Multiple Treatment Episodes | Ecallantide | Episode 2 (n = 51) | 73.3 | Standard Deviation 44.9 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00262080/results